March 25, 2026
RA Jainee
Mirae Asset Healthcare Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 42.06 |
| NAV Bonus (Rs.) | |
| NAV IDCW (Rs.) | 25.33 |
| Min. Investment (Rs.) | 5,000 |
| Min. SIP Investment (Rs.) | 99 |
| Min. No of Cheques | 5 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 2,844 Cr |
| (As on 28-Feb-2026) | |
| Expense | 0.47% |
| 1 Year Return (%) | 2.85 |
| 3 Year Return (%) | 25.39 |
| 5 Year Return (%) | 16.97 |
| 10 Year Return (%) | — |
| Return Since Launch | 20.43% |
⚖️ Sahifund Review – Mirae Asset Healthcare Fund ✔
PLUS: Stability, track record, cost efficiency
✓ This fund has delivered strong long-term consistency, with 3-year return of 25.39% and 5-year return of 16.97%, comfortably ahead of many category peers.
✓ It has also outperformed its benchmark and healthcare category across multiple time frames, which strengthens conviction.
✓ Expense ratio of 0.47% is a major positive and one of the better cost structures in the healthcare/thematic space.
✓ Portfolio is spread across 32 stocks with exposure to pharma, diagnostics and allied healthcare plays, giving decent internal diversification within the theme.
✓ The mix of large, mid and small caps allows participation in both stability and growth pockets of healthcare.
✓ Backed by Mirae Asset Mutual Fund, which adds fund house trust and research depth.
✓ For investors who specifically want a healthcare allocation, this fund looks SIP-friendly and category-relevant.
MINUS: Large AUM, large-cap bias, momentum lag
⚖️ This remains a pure sectoral/thematic bet, so risk is naturally much higher than diversified equity funds.
⚖️ Portfolio concentration is very high, with top 3 sectors at 99.72% — meaning there is virtually no cushion if healthcare underperforms.
⚖️ Top 10 holdings at 62.33% also show a relatively concentrated portfolio, which can amplify stock-specific volatility.
⚖️ Valuation is rich with portfolio P/E above 40 and P/B above 5, leaving limited room for disappointment.
⚖️ While recent returns are positive, healthcare as a theme can go through long phases of underperformance and sharp drawdowns.
⚖️ Investors looking for steady all-weather compounding may find this too cyclical and theme-dependent for core allocation.
Sahifund View (Decisive Line):
One of the stronger healthcare funds in the market, but still best used only as a small SIP-based thematic allocation — not as your main equity fund.
👉 Apply Online | Ask Us MF Queries |
| NFO Guidance |
What lies ahead? Below we decode returns consistency, portfolio concentration, peer positioning and risk profile in detail.
Suitable For Which Investors?
Nobody should invest in Pharma funds in our opinion, because:
• They have a narrow focus on only pharmaceutical and healthcare companies
• Instead, diversified equity funds which invest across sectors are better
If you still choose to invest:
1. Invest only through SIP
2. Have a 7+ year investment horizon
3. Be prepared to withstand interim sharp declines in investment value
Fund’s Investment Strategy:
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Fund Manager:
1) Tanmay Mehta
Education: B.Com, C.A.
Experience: Prior to joining the Mirae asset MF, he was associated with SBI capital markets.
2) Vrijesh Kasera
Education: Mr. Kasera is a MBA (Finance), CFA (ICFAI).
Experience: Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 99 |
| Min. Withdrawal (Rs) | — |
| Min. No of Cheques | 5 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 1% for redemption within 365 days |
Basic Details of Mirae Asset Healthcare Fund
| Fund House | Mirae Asset Mutual Fund |
| Launch Date | 2-Jul-18 |
| Return Since Launch | 20.43% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | 2,844 Cr |
| (As on 28-Feb-2026) | |
| Expense | 0.47% |
| (As on 28-Feb-2026) | |
| Risk Grade | Above Average |
| Return Grade | Below Average |
| Turnover | 31.00% |
Mirae Asset Healthcare Fund Returns
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Mirae Asset Healthcare Dir | -1.86 | -2.19 | -2.74 | -2.46 | -3.31 | 2.85 | 25.39 | 16.97 | 21.69 | — |
| BSE Healthcare TRI | -5.51 | -2.32 | -4.81 | -6.29 | -7.12 | -1.35 | 24.75 | 15.30 | 17.26 | — |
| Equity: Sectoral-Pharma | -4.90 | -2.16 | -4.55 | -5.51 | -5.99 | 0.13 | 23.42 | 15.68 | 19.98 | — |
| Rank within category | 2 | 12 | 2 | 2 | 5 | 4 | 2 | 3 | 1 | — |
| Number of funds in category | 24 | 25 | 24 | 24 | 23 | 21 | 12 | 10 | 8 | 4 |
Peer Comparison of Mirae Asset Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| Mirae Asset Healthcare Dir | 3 star | 2.85 | 25.39 | 16.97 | 0.47 | 2,844 | 20.43 | 1.00 (365) | 7Y 8M | 31.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 5 star | -0.63 | 26.62 | 17.46 | 1.04 | 6,801 | 19.50 | 1.00 (15) | 7Y 8M | 56.00 |
| SBI Healthcare Opportunities Dir | 4 star | -0.92 | 25.11 | 17.75 | 0.91 | 4,077 | 16.82 | 0.50 (15) | 13Y 2M | 22.00 |
| UTI Healthcare Dir | 4 star | 0.09 | 25.1 | 15.73 | 1.29 | 1,107 | 15.05 | 1.00 (30) | 13Y 2M | 31.00 |
| Nippon India Pharma Dir | 3 star | 0.43 | 23.15 | 15.63 | 0.91 | 8,306 | 16.81 | 1.00 (30) | 13Y 2M | 15.00 |
Mirae Asset Healthcare Fund Portfolio
| No. of Stocks | 32 |
| Top 10 Stocks | 62.33% |
| Top 5 Stocks | 39.87% |
| Top 3 Sectors | 99.72% |
| Portfolio P/B Ratio | 5.30 |
| Portfolio P/E Ratio | 40.94 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 77,276 | 80,098 |
| Giant (%) | — | — |
| Large (%) | 36.01 | 42.52 |
| Mid (%) | 34.91 | 31.81 |
| Small (%) | 29.09 | 28.41 |
| Tiny (%) | — | — |
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status